Journal of Health Sciences & Research

Register      Login

VOLUME 6 , ISSUE 2 ( July-December, 2015 ) > List of Articles


Orodental Local Drug Delivery

Nandita Ahanthem, Nikhat Gazge

Citation Information : Ahanthem N, Gazge N. Orodental Local Drug Delivery. J Health Sci Res 2015; 6 (2):41-46.

DOI: 10.5005/jp-journals-10042-1019

Published Online: 01-08-2016

Copyright Statement:  Copyright © 2015; The Author(s).


How to cite this article

Ahanthem N, Basavaraju SM, Pachipulusu B, Gazge N. Orodental Local Drug Delivery. J Health Sci Res 2015;6(2):41-46.

PDF Share
  1. Oral local drug delivery and new perspectives in oral drug formulation. Oral Surg Oral Med Oral Path Oral Radiol 2012 Sep;114(3):25-34.
  2. Oral local drug delivery: an overview. Pharm Pharmacol Res 2015 Jul;3(1):1-6.
  3. Recent trends in oral transmucosal drug delivery systems: An emphasis on the soft palate route. Exp Opin Drug Deliv 2012 Jun;9(6):629-645.
  4. Orotransmucosal drug delivery systems: A review. J Control Release 2009 Nov 16;140(1):2-11.
  5. Orodental delivery systems: an overview. Int J Pharm Pharm Sci 2013 May;5(3):74-83.
  6. The effect of the storage conditions on permeability of porcne buccal mucosa. Arch Pharm Res 2002 Aug;25(4):546-549.
  7. Glandsize estimation and body mass index improve salivary flow rate assessment. Arch Oral Biol 2007 May;52(5):409-410.
  8. Permeability and the pathophysiology of oral mucosa. Adv Drug Deliv Rev 1993;12:13-24.
  9. Oral cavity as a site for systemic drug delivery. Adv Drug Del Rev 1994;13:1-10.
  10. Local drug delivery: A review. Indian J Dental Sci 2012;4:66-69.
  11. An overview on sublingual route for systemic drug delivery. Int J Res Pharmaceut Biomed Sci 2012 Jun;3(2):913-923.
  12. Drug delivery via the mucous membranes of the oral cavity. J Pharmacol Sci 1992 Jan;81(1):1-10.
  13. New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Adv Drug Deliv Rev 2012 Jan;64(1):16-28.
  14. Buccal bioadhesive drug delivery - a promising option for orally less efficient drugs. J Control Release 2006 Aug 10;114(1):15-40.
  15. New mucosal dosage form of insulin. Chem Pharm Bull (Tokyo) 1981 Mar;29(3):810-816.
  16. Evaluation of possible mechanisms. Int J Pharm 1998;160:61-74
  17. Bioadhesive polymers as platforms for oral-controlled drug delivery: Method to study bioadhesion. Int J Pharm 1984;19:107-127.
  18. Mucoadhesive polymers for delivery of drugs to the oral cavity. Recent Pat Drug Deliv Formul 2008;2(2):108-119.
  19. Design and evaluation in vitro of controlled release mucoadhesive tablets containing chlorhexidine. Drug Dev Ind Pharm 2006 Jan;32(1):53-61.
  20. Double-layered mucoadhesive tablets containing nystatin. AAPS Pharm Sci Tech 2002 Sep;3(3):E22.
  21. Science and technology of bioadhesive-based targeted oral delivery systems. Pharma Technol 2008 Nov;32(11):100-121.
  22. Characterisation of bioadhesives for periodontal and oral mucosal drug delivery. J Clin Periodontol 1998 Jan;25(1):74-82.
  23. Local drug delivery for oral mucosal diseases challenges and opportunities. Oral Dis 2011 Apr;17(1):73-82.
  24. Recent patents on oral combination drug delivery and formulations. Recent Pat Drug Deliv Formul 2011 Jan;5(1):52-60.
  25. Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery. J Drug Target 2007 Jul;15(6):417-427.
  26. Oral mucosal drug delivery - an adjunct to the current therapeutic strategies in the dental management of oral diseases: review. Oral Health Dent Manag 2014 Dec;13(4):1034-1040.
  27. A new mucoadhesive dosage form for the management of oral lichen planus: formulation study and clinical study. Eur J Pharm Biopharm 2010 Nov;76(3):437-442.
  28. Cyclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: A double-blind, randomized controlled trial. Br J Dermatol 2006 Jan;154(1):139-145.
  29. Tacrolimus mouthwash as second-line treatment for erosive oral lichen planus. Ann Dermatol Venereol 2010 Oct;137(10):648-649.
  30. Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis. Oral Oncol 1997 Jan;33(1):47-54.
  31. Oral mucosal permeability and stability of transforming growth factor beta-3 in vitro. Pharmacol Res 1999 Oct;16(10):1557-1563.
  32. Acitretin and treatment of the oral leucoplakias. A model to have an active molecules release. J Eur Acad Dermatol Venereol 2000 Nov;14(6):473-478.
  33. Randomized, double-blind, placebo controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res 2004 Mar 1;10(5):1565-1573.
  34. Clinical response to photodynamic therapy in premalignant lesions and advanced head and neck carcinomas. Otolaryngol Pol 2003 Oct;57(4):501-504.
  35. Nanoparticles for local drug delivery to the oral mucosa: proof of principle studies. Pharmacol Res 2011 Jul;27(7):1224-1236.
  36. An evaluation on the efficacy and safety of amlexanox oral adhesive tablets in the treatment of recurrent minor aphthous ulceration in a Chinese cohort: a randomized, double-blind, vehicle-controlled, unparallel multicenter clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 Oct;102(4):475-481.
  37. The efficacy of topical 0.2% hyaluronic acid gel on recurrent oral ulcers: comparison between recurrent aphthous ulcers and the oral ulcers of Behcet's disease. J Eur Acad Dermatol Venereol 2008 May;22(5):590-595.
  38. Intraoral stimulation of salivary secretion with the cholinesterase inhibitor physostigmine as a mouth spray: a pilot study in healthy volunteers. Arch Oral Biol 2007 Nov;52(11):1097-1101.
  39. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 Mar;103(Suppl):1-15.
  40. Subgingival utilization of a 1% chlorhexidine collagen gel for the treatment of periodontal pockets. A clinical and microbiological study. Braz Dent J 2001;12(3):209-213.
  41. Mechanical and repeated antimicrobial therapy using a local drug delivery system in the treatment of peri-implantitis: a randomized clinical trial. J Periodontol 2008 May;79(5):836-844.
  42. A preparation of mucoadhesive oral patches containing tetracycline hydrochloride and carvacrol for treatment of local mouth bacterial infections and candidiasis. Sci Pharm 2011 Mar;79(1):197-212.
  43. Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease. J Control Release 2004 Mar 24;95(3):521-533.
  44. Oral candidiasis: a review. Int J Pharm Sci 2010;2(3):36-41.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.